ACT and PcbAP for Depression – A Natural Synergy Part 1: The Theoretical Intersection
Harnessing the theoretical and technical synergy between Acceptance & Commitment Therapy (ACT) and Psilocybin-Assisted Psychotherapy (PcbAP)
Harnessing the theoretical and technical synergy between Acceptance & Commitment Therapy (ACT) and Psilocybin-Assisted Psychotherapy (PcbAP)
A new clinical study reports that 20µg of LSD significantly reduces pain perception. This promising investigation builds on the little-known history of research into LSD as a potential analgesic.
"Now we know how psychedelic drugs work – finally! We might be able to switch some effects on while keeping others off."
Stronger binding interactions between MDMB-Fubinaca and CB1 may explain why some synthetic cannabinoids cause dangerous effects.
High-resolution structure reveals how LSD binds to and activates the canonical mind-altering receptor.
Connectome-Specific Harmonic Waves: A new way of looking at the brain sheds light on the biological correlates of consciousness.
"There's never been a better time to start a center like this."
Measuring and increasing post-traumatic growth may lead to more rewarding interpersonal relationships, self-esteem, and a more optimistic outlook on life.
Research indicates that ayahuasca promotes sustained decreases in neuroticism and increases in agreeableness and openness.
For humans, drug doses are based largely on body weight. But in animals, differences in brain and body chemistry make the calculations far more complicated.
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.
NEW! Shop the PSR Supporter Store to show your support for psychedelic science.